NS5A inhibitor resistance-associated polymorphisms in Brazilian treatment-naive patients infected with genotype 1 hepatitis C virus

被引:19
作者
Peres-da-Silva, Allan [1 ]
de Almeida, Adilson Jose [1 ,2 ]
Lampe, Elisabeth [1 ]
机构
[1] Fiocruz MS, Inst Oswaldo Cruz, Lab Hepatites Virais, BR-21045900 Rio De Janeiro, Brazil
[2] Univ Fed Estado Rio de Janeiro, Hosp Univ Gaffree & Guinle, Rio de Janeiro, RJ, Brazil
关键词
HCV; NS5A gene; DAAs; VARIANTS RESISTANT; NS3; PROTEASE; IN-VITRO; DACLATASVIR; THERAPY; REPLICATION; BMS-790052; PEGINTERFERON; PREVALENCE; RIBAVIRIN;
D O I
10.1093/jac/dku462
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Several promising NS5A protein inhibitors for hepatitis Cvirus (HCV) treatment, showing good antiviral activity, are currently being evaluated in clinical trials. However, viral breakthroughs associated with resistant variants have been observed, especially in patients infected with HCV-1a. We aimed to evaluate the occurrence of potential resistance mutations in the NS5A gene of HCV among Brazilian treatment-naive patients. Methods: Direct sequencing of the HCV NS5A gene was performed in serum samples of 106 treatment-naive patients infected with subtypes 1a (n = 52) and 1b (n = 54). The sequence variability, signature patterns in amino acid sequences and variants associated with NS5A inhibitors were evaluated. Results: The M28T and Y93H mutations were found in the subtype 1a sequences of two (3.85%) patients, and seven (13.46%) other patients presented the secondary mutation(s) H58P, E62D or H58P-E62D. For subtype 1b, the Y93H mutation was found in two (3.70%) patients and the substitutions R30Q, L31M, P58S and I280V were found in eight (14.81%) patients. Two distinct HCV-1a clades were distinguished by a phylogenetic analysis performed along with representative HCV-1a sequences and sequences containing HCV NS5A inhibitor resistance mutations retrieved from the Los Alamos database. All Brazilian sequences formed a large group of related sequences inside clade 1. It is noteworthy that 65.85% of sequences with substitution at sites 28, 30, 31 and 93 were found in clade 1. Conclusion: Brazilian HCV-1a sequences presented a peculiar pattern of amino acid composition, mutations and frequencies, which is distinct from other previously characterized sequences from other locations. The association of these findings with the outcome of treatment with NS5A inhibitors awaits further analysis.
引用
收藏
页码:726 / 730
页数:5
相关论文
共 20 条
[1]  
De Luca A, 2013, ANTIVIR THER, V18, pA47
[2]   Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation [J].
Fontana, Robert J. ;
Hughes, Eric A. ;
Appelman, Henry ;
Hindes, Robert ;
Dimitrova, Dessislava ;
Bifano, Marc .
LIVER TRANSPLANTATION, 2012, 18 (09) :1053-1059
[3]   Genotypic and Phenotypic Analysis of Variants Resistant to Hepatitis C Virus Nonstructural Protein 5A Replication Complex Inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations [J].
Fridell, Robert A. ;
Wang, Chunfu ;
Sun, Jin-Hua ;
O'Boyle, Donald R., II ;
Nower, Peter ;
Valera, Lourdes ;
Qiu, Dike ;
Roberts, Susan ;
Huang, Xin ;
Kienzle, Bernadette ;
Bifano, Marc ;
Nettles, Richard E. ;
Gao, Min .
HEPATOLOGY, 2011, 54 (06) :1924-1935
[4]   Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System [J].
Fridell, Robert A. ;
Qiu, Dike ;
Wang, Chunfu ;
Valera, Lourdes ;
Gao, Min .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (09) :3641-3650
[5]   Antiviral activity and resistance of HCV NS5A replication complex inhibitors [J].
Gao, Min .
CURRENT OPINION IN VIROLOGY, 2013, 3 (05) :514-520
[6]   Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect [J].
Gao, Min ;
Nettles, Richard E. ;
Belema, Makonen ;
Snyder, Lawrence B. ;
Nguyen, Van N. ;
Fridell, Robert A. ;
Serrano-Wu, Michael H. ;
Langley, David R. ;
Sun, Jin-Hua ;
O'Boyle, Donald R. ;
Lemm, Julie A. ;
Wang, Chunfu ;
Knipe, Jay O. ;
Chien, Caly ;
Colonno, Richard J. ;
Grasela, Dennis M. ;
Meanwell, Nicholas A. ;
Hamann, Lawrence G. .
NATURE, 2010, 465 (7294) :96-U108
[7]   Analysis of HCV quasispecies dynamic under selective pressure of combined therapy [J].
Jardim, Ana C. G. ;
Bittar, Cintia ;
Matos, Renata P. A. ;
Yamasaki, Lilian H. T. ;
Silva, Rafael A. ;
Pinho, Joao R. R. ;
Fachini, Roberta M. ;
Carareto, Claudia M. A. ;
de Carvalho-Mello, Isabel M. V. G. ;
Rahal, Paula .
BMC INFECTIOUS DISEASES, 2013, 13
[8]   SIGNATURE PATTERN-ANALYSIS - A METHOD FOR ASSESSING VIRAL SEQUENCE RELATEDNESS [J].
KORBER, B ;
MYERS, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (09) :1549-1560
[9]   Ultradeep Sequencing Study of Chronic Hepatitis C Virus Genotype 1 Infection in Patients Treated with Daclatasvir, Peginterferon, and Ribavirin [J].
Murakami, Eisuke ;
Imamura, Michio ;
Hayes, C. Nelson ;
Abe, Hiromi ;
Hiraga, Nobuhiko ;
Honda, Yoji ;
Ono, Atsushi ;
Kosaka, Keiichi ;
Kawaoka, Tomokazu ;
Tsuge, Masataka ;
Aikata, Hiroshi ;
Takahashi, Shoichi ;
Miki, Daiki ;
Ochi, Hidenori ;
Matsui, Hirotaka ;
Kanai, Akinori ;
Inaba, Toshiya ;
McPhee, Fiona ;
Chayama, Kazuaki .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) :2105-2112
[10]   NS5A inhibitors in the treatment of hepatitis C [J].
Pawlotsky, Jean-Michel .
JOURNAL OF HEPATOLOGY, 2013, 59 (02) :375-382